Mumps Virus Epidemiology and Vaccine Effectiveness

Summary

Mumps virus remains a global public health concern despite widespread implementation of measles–mumps–rubella (MMR) vaccination programmes. Introduction of two-dose MMR schedules led to a dramatic decline in incidence and complications such as orchitis and meningitis. However, in several countries a resurgence of mumps has been observed among adolescents and young adults, often within highly vaccinated communities. This resurgence reflects a combination of factors including waning immunity over time, heterogeneous vaccine uptake, viral transmission in densely populated settings and occasional mismatch between vaccine and circulating genotypes. Vaccine effectiveness is high in the first years following immunisation but may decline, leading to outbreaks in settings such as universities and military barracks. To mitigate these events, health authorities have recommended third-dose booster campaigns for groups at elevated risk during outbreaks. Advances in molecular epidemiology have enabled genome-based tracing of transmission chains, revealing persistent lineages despite high coverage and demonstrating that viral evolution alone has not driven vaccine escape. Practical applications of this research include refining immunisation schedules, targeting booster doses, improving surveillance of genotype circulation and exploring next-generation vaccine formulations. Efforts to maintain high coverage, monitor immunity over time and integrate genomic surveillance are central to controlling mumps globally and preventing severe complications.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Mumps Virus Epidemiology and Vaccine Effectiveness publication trend

The graph below shows the total number of articles in mumps virus epidemiology and vaccine effectiveness across all publications each year (not limited to Nature Index journals).

Technical terms

Vaccine effectiveness: The percentage reduction in disease incidence among vaccinated individuals compared with unvaccinated individuals under field conditions.

Waning immunity: The gradual loss of protective immune response following vaccination, leading to increased susceptibility over time.

Seroconversion: The development of detectable specific antibodies in the blood serum as a result of infection or immunisation.

Genotype: A classification of virus strains based on genetic sequence, used to monitor circulating variants and transmission patterns.

References

  1. Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus–Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak. MMWR Morbidity and Mortality Weekly Report (2018).
  2. Waning immunity against mumps in vaccinated young adults, France 2013.. Eurosurveillance (2016).
  3. Combining genomics and epidemiology to track mumps virus transmission in the United States. PLOS Biology (2020).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.